Literature DB >> 35585763

Safety of combining biologics in severe asthma: Asthma-related and unrelated combinations.

Marek Lommatzsch1, Hendrik Suhling2, Stephanie Korn3, Karl-Christian Bergmann4, Jens Schreiber5, Thomas Bahmer6, Klaus F Rabe7, Roland Buhl8, Johann Christian Virchow1, Katrin Milger9.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35585763     DOI: 10.1111/all.15379

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   14.710


× No keyword cloud information.
  1 in total

1.  Combining Biologics Targeting Eosinophils (IL-5/IL-5R), IgE, and IL-4/IL-13 in Allergic and Inflammatory Diseases.

Authors:  Mitchell M Pitlick; Thanai Pongdee
Journal:  World Allergy Organ J       Date:  2022-10-13       Impact factor: 5.516

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.